ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm	Recruiting	Phase 1	2026-08-18		NCT06656494

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing InnoCare Pharma Tech Co., Ltd.	26

22 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Anhui Provincial Hospita	Hefei	China	1
Chao Family Comprehensive Cancer Center, University of California, Irvine	Orange	United States	1
Guangdong Provincial People's Hospital	Guangzhou	China	3
H Lee Moffitt Cancer Center & Research Institute	Tampa	United States	2
Henan Cancer Hospital	Zhengzhou	China	76
Medical College of Wisconsin	Milwaukee	United States	483
Nanfang Hospital Southern Medical University	Guangzhou	China	8
NYU Langone Health	New York	United States	403
Peking University People's Hospital	Beijing	China	146
Royal Perth Hospital	Perth	Australia	43
Shengjing Hospital of China Medical University	Shengyang	China	2
Sichuan Provincial People's Hospital	Chengdu	China	50
St Vincent's Hospital	Sydney	Australia	12
The First Affiliated Hospital of Chongqing Medical University	Chongqing	China	7
The First Affiliated Hospital of Nanchang University	Nanchang	China	109
The First Affiliated Hospital of Soochow University	Suzhou	China	101
The First Affiliated Hospital, Zhejiang University School of Medicine	Hangzhou	China	1
The First Hospital of Jilin University	Changchun	China	46
Tianjin People's Hospital	Tianjin	China	2
Union Hospital Tongji Medical College Huazhong University of Science and Technology	Wuhan	China	12
University of North Carolina at Chapel Hill	Chapel Hill	United States	2
Yale University, Yale Cancer Center	New Haven	United States	7

Clinical trials